Phase IV Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients

NCT00084253 Phase 4 COMPLETED

The purpose of this study is to find out if 300 mg of ATV plus 100 mg of ritonavir (RTV) works as well as 400 mg of ATV alone as part of a regimen with stavudine XR and lamivudine to slow or stop the progression of HIV infection in patients who have never used anti-HIV drugs.

Details

Lead sponsor	Bristol-Myers Squibb
Phase	Phase 4
Status	COMPLETED
Enrolment	200
Start date	2004-06

Conditions

• HIV Infections

Interventions

• Atazanavir/ Stavidine / Lamivudine
• Atazanavir-Ritonavir/ Stavidine / Lamivudine

Primary outcomes

• To compare the proportion of subjects responding to treatment with HIV RNA levels < LOQ (400 c/mL) through Week 48 in treatment naive subjects for ATV and ATV/RTV (each combined with 3TC and d4T XR).

Countries

United States